Dretzke Janine, Hobart Carla, Basu Anamika, Ahyow Lauren, Nagasivam Ahimza, Moore David J, Gajraj Roger, Roy Anjana
Institute of Applied Health Research, University of Birmingham, Birmingham, UK
UK Health Security Agency, London, UK.
BMJ Open. 2024 Mar 11;14(3):e080827. doi: 10.1136/bmjopen-2023-080827.
People in underserved groups have higher rates of tuberculosis (TB) and poorer treatment outcomes compared with people with no social risk factors.
This scoping review aimed to identify interventions that improve TB treatment adherence or completion rates.
Studies of any design focusing on interventions to improve adherence or completion of TB treatment in underserved populations in low incidence countries.
MEDLINE, Embase and Cochrane CENTRAL were searched (January 2015 to December 2023).
Piloted data extraction forms were used. Findings were tabulated and reported narratively. Formal risk of bias assessment or synthesis was not undertaken.
47 studies were identified. There was substantial heterogeneity in study design, population, intervention components, usual care and definition of completion rates. Most studies were in migrants or refugees, with fewer in populations with other risk factors (eg, homelessness, imprisonment or substance abuse). Based on controlled studies, there was limited evidence to suggest that shorter treatment regimens, video-observed therapy (compared with directly observed therapy), directly observed therapy (compared with self-administered treatment) and approaches that include tailored health or social support beyond TB treatment may lead to improved outcomes. This evidence is mostly observational and subject to confounding. There were no studies in Gypsy, Roma and Traveller populations, or individuals with mental health disorders and only one in sex workers. Barriers to treatment adherence included a lack of knowledge around TB, lack of general health or social support and side effects. Facilitators included health education, trusted relationships between patients and healthcare staff, social support and reduced treatment duration.
The evidence base is limited, and few controlled studies exist. Further high-quality research in well-defined underserved populations is needed to confirm the limited findings and inform policy and practice in TB management. Further qualitative research should include more people from underserved groups.
与无社会风险因素的人群相比,医疗服务不足群体的结核病(TB)发病率更高,治疗效果更差。
本综述旨在确定可提高结核病治疗依从性或完成率的干预措施。
针对低发病率国家医疗服务不足人群中提高结核病治疗依从性或完成率的干预措施的任何设计的研究。
检索了MEDLINE、Embase和Cochrane CENTRAL(2015年1月至2023年12月)。
使用了预先试验的数据提取表。研究结果列表呈现并进行叙述性报告。未进行正式的偏倚风险评估或综合分析。
共纳入47项研究。研究设计、人群、干预措施组成部分、常规护理和完成率定义存在很大异质性。大多数研究针对移民或难民,针对其他风险因素人群(如无家可归者、囚犯或药物滥用者)的研究较少。基于对照研究,仅有有限证据表明较短的治疗方案、视频观察治疗(与直接观察治疗相比)、直接观察治疗(与自我给药治疗相比)以及包括结核病治疗之外的个性化健康或社会支持的方法可能会改善治疗效果。这些证据大多为观察性的,且存在混杂因素。未对吉普赛、罗姆和游民群体或有精神健康障碍的个体进行研究,性工作者中仅有一项研究。治疗依从性的障碍包括对结核病缺乏了解、缺乏一般健康或社会支持以及副作用。促进因素包括健康教育、患者与医护人员之间的信任关系、社会支持和缩短治疗时间。
证据基础有限,对照研究较少。需要在明确界定的医疗服务不足人群中开展进一步的高质量研究,以证实有限的研究结果,并为结核病管理的政策和实践提供信息。进一步的定性研究应纳入更多医疗服务不足群体的人群。